General information

Contacts

Industries

Jah

VAT liability

Annual reports

✓

Unsubmitted declarations

???

Credit rating

Tax data

✓

Tax debts

Related persons

Holdings in companies

Statistics

Summary of reports

Licenses

Regulations

Real estate

TTJA decisions

Court decisions

Official announcements

1.2K

Public transactions

.ee domains

✓

Enforcement proceedings

✓

Payment orders

Celvia CC AS

Legal form:

Public limited company

Registry code:

11673707

VAT no.:

EE101318989

Fiscal-year period:

01.01 - 31.12

Established:

12.08.2009 (16)

Former business names:

Reproduktiivmeditsiini ja -bioloogia Tehnoloogia Arenduskeskuse AS, Reproduktiivmeditsiini TAK AS, Tervisetehnoloogiate Arenduskeskus AS

Capital:

25 756 EUR

Address:

Teaduspargi tn 13, Tartu linn, Tartu linn, Tartu maakond, 50411

Status:

Registered

E-arvete vastuvõtmine:

Arvekeskus

Contacts

Email:

info@celvia.ee

Phone:

+372 7330401

Website:

https://celvia.ee

Industries

PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Research and development
72101 - Research and experimental development on natural and technical sciences
HEALTH CARE AND SOCIAL WORK
Health care
Other health activities
86911 - Imaging diagnostic services and activities of medical laboratories

VAT liability

	Start	End
EE101318989	01.10.2009

Annual reports

Aggregate data

	Period	Submitted
2025	01.01.2025 - 31.12.2025	30.06.2026	Valid
2024	01.01.2024 - 31.12.2024	30.06.2025	Valid
2023	01.01.2023 - 31.12.2023	27.06.2024	Valid
2022	01.01.2022 - 31.12.2022	30.06.2023	Valid
2021	01.01.2021 - 31.12.2021	21.06.2022	Valid
2020	01.01.2020 - 31.12.2020	29.06.2021	Valid
2019	01.01.2019 - 31.12.2019	26.06.2020	Valid
2018	01.01.2018 - 31.12.2018	27.06.2019	Valid
2017	01.01.2017 - 31.12.2017	28.06.2018	Valid
2016	01.01.2016 - 31.12.2016	27.06.2017	Valid
2015	01.01.2015 - 31.12.2015	30.06.2016	Valid
2014	01.01.2014 - 31.12.2014	29.06.2015	Valid
2013	01.01.2013 - 31.12.2013	27.06.2014	Valid
2012	01.01.2012 - 31.12.2012	26.06.2013	Valid
2011	01.01.2011 - 31.12.2011	04.06.2012	Valid
2010	12.08.2009 - 31.12.2010	28.06.2011	Valid

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 21.07.2026.

???

Credit rating

Hidden

Credit rating is based on company financial data and payment behavior. detailed analysis available to regia+ users.

020406080100

? Risk factors

? Strengths

View summary

✓

Tax debt

✓

Unsubmitted reports

✓

Unsubmitted declarations

Court decisions

Official announcements

TTJA decisions

Real estate

.ee domains

Licenses

Regulations

1.2K

Public transactions

Holdings in companies

✓

Enforcement proceedings

✓

Payment orders

Tax data

	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q2	151 931 €	164 482 €	326 416 €17.8%	48
2026 Q1	191 263 €	173 246 €	397 295 €59.8%	44
Kokku 2026:	343 194 €	337 728 €	723 711 €
2025 Q4	148 131 €	159 220 €	248 590 €73.0%	42
2025 Q3	150 288 €	162 608 €	143 679 €66.6%	40
2025 Q2	180 954 €	161 656 €	430 395 €15.0%	48
2025 Q1	143 879 €	136 729 €	374 254 €37.5%	47
Kokku 2025:	623 252 €	620 213 €	1 196 918 €60.3%
2024 Q4	131 032 €	135 222 €	272 194 €94.9%	44
2024 Q3	130 736 €	138 834 €	139 659 €10.6%	41
2024 Q2	139 691 €	133 417 €	156 224 €12.4%	44
2024 Q1	135 358 €	145 705 €	178 384 €25.9%	44
Kokku 2024:	536 817 €	553 178 €	746 461 €26.3%
2023 Q4	139 605 €	141 283 €	240 773 €30.4%	44
2023 Q3	118 222 €	127 618 €	346 139 €29.0%	51
2023 Q2	120 363 €	115 392 €	268 417 €70.2%	56
2023 Q1	103 158 €	110 732 €	157 714 €2.3%	51
Kokku 2023:	481 348 €	495 024 €	1 013 042 €84.3%
2022 Q4	99 828 €	94 761 €	161 378 €111.4%	45
2022 Q3	90 695 €	96 014 €	76 322 €62.1%	39
2022 Q2	92 431 €	85 376 €	201 413 €82.3%	46
2022 Q1	111 184 €	119 016 €	110 461 €43.7%	48
Kokku 2022:	394 138 €	395 166 €	549 574 €32.8%
2021 Q4	101 647 €	88 920 €	196 247 €172.6%	47
2021 Q3	87 229 €	90 559 €	71 992 €65.3%	48
2021 Q2	109 138 €	101 118 €	207 354 €39.3%	45
2021 Q1	101 921 €	98 064 €	341 674 €83.4%	48
Kokku 2021:	399 934 €	378 662 €	817 268 €19.5%
2020 Q4	87 324 €	81 962 €	186 278 €32.4%	51
2020 Q3	80 829 €	76 359 €	140 736 €45.9%	47
2020 Q2	93 316 €	71 889 €	260 108 €168.7%	38
2020 Q1	62 107 €	62 243 €	96 815 €15.8%	35
Kokku 2020:	323 575 €	292 453 €	683 937 €78.0%
2019 Q4	56 097 €	59 971 €	83 639 €19.8%	33
2019 Q3	53 921 €	54 105 €	104 348 €39.5%	37
2019 Q2	45 746 €	47 719 €	74 800 €38.4%	36
2019 Q1	52 839 €	49 228 €	121 443 €101.3%	28
Kokku 2019:	208 603 €	211 023 €	384 230 €13.7%
2018 Q4	45 640 €	49 428 €	60 332 €45.0%	37
2018 Q3	51 187 €	49 735 €	109 691 €120.3%	36
2018 Q2	47 963 €	50 552 €	49 781 €57.8%	32
2018 Q1	60 432 €	55 957 €	118 094 €106.1%	34
Kokku 2018:	205 222 €	205 672 €	337 898 €35.2%
2017 Q4	53 340 €	57 754 €	57 288 €27.2%	39
2017 Q3	58 616 €	58 124 €	78 661 €114.8%	43
2017 Q2	52 763 €	55 438 €	36 622 €52.7%	43
2017 Q1	75 418 €	77 754 €	77 367 €216.5%	42
Kokku 2017:	240 137 €	249 070 €	249 938 €148.3%
2016 Q4	71 897 €	77 260 €	24 443 €8.5%	25
2016 Q3	85 686 €	84 454 €	26 719 €5.9%	25
2016 Q2	73 893 €	79 785 €	25 242 €4.0%	25
2016 Q1	70 993 €	76 722 €	24 273 €52.1%	25
Kokku 2016:	302 469 €	318 221 €	100 677 €77.6%
2015 Q4	41 590 €	45 014 €	50 678 €70.1%	33
2015 Q3	139 468 €	150 424 €	169 348 €48.9%	33
2015 Q2	93 695 €	101 020 €	113 729 €1.5%	33
2015 Q1	103 719 €	102 605 €	115 514 €	33
Kokku 2015:	378 472 €	399 063 €	449 269 €

Revenue by industry

	2023	2024	2025
Imaging diagnostic services and activities of medical laboratories		1 459 118 €	2 392 283 €
Research and experimental development on natural and technical sciences		337 674 €	419 337 €
Activities of medical laboratories and blood, sperm, etc. banks	1 185 205 €
Research and development in biotechnology	296 501 €

Tax debts

No tax debt found

No tax debt as of 21.07.2026

Representatives

Name	Personal ID code	Date of birth	Role	Start	End
Kaarel Krjutškov	38103XXXXXX	14.03.1981 (45)	Board member	13.09.2022	-
Andres Salumets	37105XXXXXX	19.05.1971 (55)	Board member	12.08.2009	-

4 inactive record hidden, extended access to the information portal is required to view history!

1 - 2 / 2 rows

Shareholders

Name	Personal ID code	Date of birth	Role	Share	%	Type	Start	End
Andres Salumets	37105XXXXXX	19.05.1971 (55)	Shareholder	12 878,00 EUR	50	Sole ownership	18.02.2026	-
Kaarel Krjutškov	38103XXXXXX	14.03.1981 (45)	Shareholder	8 915,54 EUR	34,62	Sole ownership	18.02.2026	-

22 inactive record hidden, extended access to the information portal is required to view history!

1 - 2 / 2 rows

Other persons

Name	Personal ID code	Date of birth	Role	Start	End
Jaanus Pikani	35912XXXXXX	29.12.1959 (66)	Supervisory-board member	01.04.2025	-
Ülle Jaakma	45710XXXXXX	01.10.1957 (68)	Supervisory-board member	01.04.2025	-
Sander Salumets	50012XXXXXX	17.12.2000 (25)	Supervisory-board member	01.04.2025	-
AUDIITORBÜROO ELSS OÜ	-	-	Audit firm	29.06.2018	-
aktsiaselts Asper Biotech	-	-	Founder	26.06.2009	-

25 inactive record hidden, extended access to the information portal is required to view history!

1 - 5 / 16 rows

Ultimate beneficial owners

Name	Personal ID code	Date of birth	Role	Start	End
Andres Salumets	37105XXXXXX	19.05.1971 (55)	Direct holding	23.01.2025	-
Kaarel Krjutškov	38103XXXXXX	14.03.1981 (45)	Direct holding	23.01.2025	-

1 inactive record hidden, extended access to the information portal is required to view history!

1 - 2 / 2 rows

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

1 inactive record hidden, extended access to the information portal is required to view history!

2026 Q2

Turnover

Amount

326 416 €

Monthly average

108 805 €

Per employee

2 267 €

Equity ratio

422,45%

Labour taxes

Turnover ratio

50,39%

Tax ratio

108,26%

Monthly average

54 827 €

Per employee

1 192 €

State taxes

Monthly average

50 644 €

Turnover ratio

46,55%

Estimated salary

Gross salary

2 249 €

Net salary

1 817 €

Aggregate data

	2025	2024	2023	2022	2021	2020	2019
Current assets	1 875 702 €77.2%	1 058 554 €19.8%	1 320 326 €55.5%	848 915 €7.6%	919 073 €3.4%	888 896 €121.2%	401 812 €
Non-current assets	250 246 €13.1%	288 013 €84.7%	155 956 €184.7%	54 784 €104.0%	26 859 €44.5%	48 362 €11.1%	54 397 €
Total assets	2 125 948 €57.9%	1 346 567 €8.8%	1 476 282 €63.4%	903 699 €4.5%	945 932 €0.9%	937 258 €105.4%	456 209 €
Short-term liabilities	953 482 €27.2%	749 806 €25.0%	999 656 €129.3%	435 939 €27.5%	601 218 €5.0%	632 858 €153.4%	249 747 €
Long-term liabilities	91 190 €14.2%	106 271 €325.1%	-	25 000 €	25 000 €50.0%	50 000 €	-
Total liabilities	1 044 672 €22.0%	856 077 €14.4%	999 656 €116.9%	460 939 €26.4%	626 218 €8.3%	682 858 €173.4%	249 747 €
Share or stock capital	25 756 €	25 756 €	25 756 €	25 756 €	25 756 €	25 756 €	25 756 €
Retained earnings	464 734 €3.1%	450 870 €8.1%	417 004 €41.9%	293 958 €28.6%	228 644 €22.5%	186 650 €16.3%	160 494 €
Net profit	590 786 €4 161.3%	13 864 €59.1%	33 866 €72.5%	123 046 €88.4%	65 314 €55.5%	41 994 €107.8%	20 212 €
Equity	1 081 276 €120.4%	490 490 €2.9%	476 626 €7.6%	442 760 €38.5%	319 714 €25.7%	254 400 €23.2%	206 462 €
Turnover	2 811 620 €56.5%	1 796 792 €21.3%	1 481 706 €33.6%	1 109 400 €7.3%	1 196 230 €1.9%	1 218 973 €169.5%	452 355 €
Profit margin	21.01%2 623.2%	0.77%66.2%	2.29%79.4%	11.09%103.1%	5.46%58.5%	3.45%22.9%	4.47%

Financial ratios

	2025	2024	2023	2022	2021
Profit and cash flow
EBITDA	UBR YVK	SI EJG	JM USW	146 581	85 395
Liquidity
Current ratio	J.W	Y.S	J.D	1.9	1.5
Quick ratio	C.U	G.R	D.O	1.9	1.5
Cash ratio	T.E	M.Q	V.Y	1.1	0.8
Efficiency
Days sales outstanding (dso)	DK.R	KGR.N	OMO.L	127.2	133.5
Asset turnover	P.A	U.A	K.B	1.2	1.3
Structure
Debt ratio	Z.Z	D.E	S.I	0.5	0.7
Profitability
Operating margin	TR.B%	-V.K%	U.C%	11.1%	5.4%
Net profit margin	GL.D%	X.E%	C.C%	11.1%	5.5%
Return on assets (roa)	FT.X%	H.T%	T.O%	13.3%	6.9%
Return on equity (roe)	RL.A%	T.E%	X.G%	27.8%	20.4%

To view all financial ratios, you need to subscribe to extended access to the info portal!

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations

Regulation no.	Date	Type	Deadline	Status
Ä 20046093 / 20	07.10.2025	Entry - Amendment entry		Entered into force (07.10.2025)
Ä 20046093 / 19	08.07.2025	Entry - Amendment entry		Entered into force (08.07.2025)
Ä 20046093 / M13	02.05.2025	Order to remedy deficiencies for correcting extra-entry data	16.05.2025	Entered into force (02.05.2025)
Ä 20046093 / 18	04.07.2024	Entry - Amendment entry		Entered into force (04.07.2024)
Ä 20046093 / 17	12.03.2024	Negative entry order – deficiencies not remedied - Amendment entry		Entered into force (01.04.2024)

1 - 5 / 33 rows

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Official announcements

Subject	Date
Notice of issuance of a licence to handle infectious material	22.02.2018

1 - 1 / 1 rows

Public transactions

Date	Party	Amount	Classification
30.06.2026	Aktsiaselts Lääne-Tallinna Keskhaigla	6 125.00 € Received	OPERATING EXPENSES Specialized hospital services
30.06.2026	Aktsiaselts Lääne-Tallinna Keskhaigla	5 260.00 € Received	OPERATING EXPENSES Specialized hospital services
30.06.2026	sihtasutus Tartu Ülikooli Kliinikum	7 976.00 € Received	OPERATING EXPENSES General hospital services
25.06.2026	sihtasutus Tartu Ülikooli Kliinikum	1 320.00 € Received	OPERATING EXPENSES General hospital services
17.06.2026	Haridus- ja Teadusministeerium	11 505.20 € Received	OTHER GRANTS R&D in education

1 - 5 / 1189 rows

.ee domains

Domain	Status	Registered	Expires	End
celvia.ee	Active	04.04.2024	05.04.2027	-
invisiblemi.ee	Active	05.04.2023	06.04.2027	-
fertify.ee	Active	21.08.2020	22.08.2026	-
orderbeready.ee	Active	11.06.2019	12.06.2027	-
beready.ee	Active	21.03.2019	22.03.2027	-

1 - 5 / 9 rows

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders